Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …

The recently uncovered key role of the peripheral and central nervous systems in controlling
tumorigenesis and metastasis has opened a new area of research to identify innovative …

Background. Breast cancer is the most common cancer in Chinese women. Inflammation
contributes to tumor progression and can be induced by excessive production of pro …

Many cancer patients treated with chemotherapy develop chemotherapy-induced cognitive
impairment (CICI), often referred to as chemo-brain, which manifest during or post-treatment …

Survivors of early-stage breast cancer may report treatment-related side effects that persist
for several years after the end of primary treatment. Among these, fatigue and cognitive …

Purpose Cognitive symptoms are common in cancer patients, with up to 70% reporting
cognitive symptoms following chemotherapy. These symptoms can have a major impact on …

Cognitive impairment is a debilitating side effect experienced by patients with cancer treated
with systemically administered anticancer therapies. With around 19.3 million new cases of …

Background Inflammation is an important candidate mechanism underlying cancer and
cancer treatment-related cognitive impairment. We investigated levels of blood cell–based …

This randomized, double-blinded, placebo-controlled trial tested the hypothesis that 20mg of
melatonin before and during the first cycle of adjuvant chemotherapy for breast cancer …